[On the use of some new antibiotics in the therapy of neonatal infections due to gram-negative bacilli. II. Bacteriologic studies].
D000421:Alcaligenes / Q000187:drug effects; D002509:Cephaloridine / Q000494:pharmacology*; D003091:Colistin / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004754:Enterobacter / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007612:Kanamycin / Q000494:pharmacology*; D007709:Klebsiella / Q000187:drug effects; D011113:Polymyxins / Q000494:pharmacology*; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects
D011113:Polymyxins; D007612:Kanamycin; D002509:Cephaloridine; D003091:Colistin
Sull'impiego di alcuni nuovi antibiotici nella terapia delle infezioni neonatali da bacilli gram-negativi. II. Studio batteriologico.